Europe | Science and Enterprise

The federal health preparedness agency is spending more than $2 billion for developers to produce Covid-19 vaccines… https://t.co/7P1yBG9iO5
about 13 hours ago
New post on Science and Enterprise: BARDA to Buy $2B in Covid-19 Vaccines, Therapies https://t.co/LFM1IUr1rN #Science #Business
about 13 hours ago
A company designing gene-edited T-cells as cancer therapies stopped its clinical trial of a treatment for multiple… https://t.co/0PktfkzyNH
about 20 hours ago
New post on Science and Enterprise: FDA Halts Off-the-Shelf Engineered T-Cell Trial https://t.co/Fbz7IKCgky #Science #Business
about 20 hours ago
If you dig deep into the Science & Enterprise archives, you'll find this site began posting on 6 July 2010, exactly… https://t.co/eGPudMExsK
about 2 days ago

Mobile App Screens for Sleep Apnea

By Alan, on July 3rd, 2020%

A medical software team designed a mobile app that records and analyzes a person’s sounds and sleep positions to detect signs of sleep apnea. . . . → Read More: Mobile App Screens for Sleep Apnea

Virtual Drug Discovery Incubator Launched for Univ. Labs

By Alan, on June 24th, 2020%

Life science investors and a drug discovery company started a remote business incubator service to discover and develop early therapy candidates from academic research. . . . → Read More: Virtual Drug Discovery Incubator Launched for Univ. Labs

Industry, Univ. Labs Partner on Covid-19 Therapy

By Alan, on June 5th, 2020%

Researchers from industry and academic labs are developing a synthetic antibody that in lab tests shows promise as both a Covid-19 therapy and vaccine. . . . → Read More: Industry, Univ. Labs Partner on Covid-19 Therapy

Fix Discovered for Gene Therapy Virus Delivery

By Alan, on June 2nd, 2020%

Researchers in France and the U.S. discovered a bacterial enzyme that blocks immune reactions to otherwise benign viruses that deliver gene therapies. . . . → Read More: Fix Discovered for Gene Therapy Virus Delivery

Drug Maker Licenses Low-Dose Vaccine Patch

By Alan, on May 28th, 2020%

The pharmaceutical company Merck is licensing a microneedle patch device that delivers vaccines with a small fraction of the dose normally needed by syringes. . . . → Read More: Drug Maker Licenses Low-Dose Vaccine Patch

Merck Inks Three Covid-19 Vaccine, Therapy Deals

By Alan, on May 26th, 2020%

Drug maker Merck today gained a new acquisition, along with collaboration and licensing deals, for vaccines and a therapy for Covid-19 infections. . . . → Read More: Merck Inks Three Covid-19 Vaccine, Therapy Deals

Depression Therapy Licensed for Online Distribution

By Alan, on May 25th, 2020%

A therapy program for depression designed to reduce spirals of repeated negative thinking is licensed to a digital mental health company for online use. . . . → Read More: Depression Therapy Licensed for Online Distribution

Antibody Neutralizes Covid-19, SARS Viruses

By Alan, on May 19th, 2020%

An academic-industry team discovered that an antibody produced during the 2003 SARS outbreak can neutralize similar viruses causing Covid-19 infections. . . . → Read More: Antibody Neutralizes Covid-19, SARS Viruses

Covid-19 Lung Disease Trial Adds Treatments

By Alan, on May 14th, 2020%

A clinical trial testing treatments for lung damage in severe Covid-19 cases is adding the anti-viral drug remdesivir and convalescent plasma to its protocol. . . . → Read More: Covid-19 Lung Disease Trial Adds Treatments

Int’l Group Backs Novavax Covid-19 Vaccine

By Alan, on May 12th, 2020%

A global consortium is funding a biotechnology company’s clinical trials and manufacturing plans for a vaccine protecting against Covid-19 viruses. . . . → Read More: Int’l Group Backs Novavax Covid-19 Vaccine

Science & Enterprise subscription

Specials

Follow us on Twitter

Guest Posts

Please share Science & Enterprise